(Q30810191)

26 June 2017

1 reference

title

Multiple sclerosis in the Japanese population (English)

1 reference

26 June 2017

0 references

Jun-ichi Kira

1

1 reference

26 June 2017

publication date

1 February 2003

1 reference

26 June 2017

1 reference

26 June 2017

volume

2

1 reference

26 June 2017

issue

2

1 reference

26 June 2017

page(s)

117-127

1 reference

Nationwide survey of multiple sclerosis in Japan Clinical analysis of 1,084 cases

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Multiple sclerosis and allied diseases in Japan; clinical characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Multiple sclerosis in Korea. Clinical features and prevalence

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Profile of multiple sclerosis in the bombay region. On the basis of critical clinical appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Multiple sclerosis amongst Chinese in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Multiple sclerosis in Asia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Multiple sclerosis in North-West India.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Multiple sclerosis. A clinical study of 70 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

The clinical course of neuromyelitis optica (Devic's syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Multiple sclerosis amongst Chinese in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Multiple Sclerosis in Malaysia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Multiple sclerosis in Saudi Arabia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Epidemiology of multiple sclerosis in Arabs in Kuwait: a comparative study between Kuwaitis and Palestinians

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Multiple sclerosis in Arabs in Jordan

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Multiple sclerosis is prevalent in the Zoroastrians (Parsis) of India

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Epidemiologic contributions to multiple sclerosis: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Genomic HLA profiles of MS in Hokkaido, Japan: important role of DPB1*0501 allele

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Clinical and MRI study of brain stem and cerebellar involvement in Japanese patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Multiple sclerosis among Orientals and Caucasians in Hawaii: A reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Optic neuritis in African Americans

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

The pattern of neurological illness in tropical Africa. Experience at Ibadan, Nigeria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

MS and neuromyelitis optica in Martinique (French West Indies)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

HLA-DR and -DQ associations with multiple sclerosis in Turkey

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

No apparent association between HLA and multiple sclerosis in southern Chinese

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Genetic susceptibility to multiple sclerosis in a Shanghai Chinese population. The role of the HLA class II genes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

HLA-DRB1, -DQA1, -DQB1, -DPA1 and -DPB1 genes in Japanese multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

HLA profiles of multiple sclerosis in Hokkaido, the northernmost island of Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Histocompatibility antigen (HLA) associations with multiple sclerosis in Iran

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Sclerosis multiplex in gypsies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Relapses and progression of disability in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Cerebrospinal fluid IgG profiles and multiple sclerosis in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Oligoclonal IgG bands in Japanese multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Multiple sclerosis: Indian experience in the last thirty years

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Multiple sclerosis in Kuwait: clinical and epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

The significance of oligoclonal bands in multiple sclerosis in Japan: relevance of immunogenetic backgrounds

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Two unusual neuropathologically proven cases of multiple sclerosis from bombay

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Devic's neuromyelitis optica: a clinicopathological study of 8 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Neuromyelitis optica (Devic's syndrome) and pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Progressive necrotic myelopathy: clinical course in 9 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

HLA-DRB1 and tumor necrosis factor gene polymorphisms in Japanese patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Both the HLA-CPB1 and -DRB1 alleles correlate with risk for multiple sclerosis in Japanese: clinical phenotypes and gender as important factors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Molecular analysis of HLA class I (HLA-A and -B) and HLA class II (HLA-DRB1) genes in Japanese patients with multiple sclerosis (Western type and Asian type)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

HLA-DP-associated susceptibility to the optico-spinal form of multiple sclerosis in the Japanese

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

No association of vitamin D-binding protein gene polymorphisms in Japanese patients with MS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Estrogen receptor gene polymorphism in Japanese patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Estrogen receptor gene polymorphism and multiple sclerosis in Japanese patients: interaction with HLA-DRB1*1501 and disease modulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Genetic polymorphisms of IL-1beta and IL-1 receptor antagonist in association with multiple sclerosis in Japanese patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Heat shock protein 70 gene polymorphism in Japanese patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Th1 dominance in HAM/TSP and the optico-spinal form of multiple sclerosis versus Th2 dominance in mite antigen-specific IgE myelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Tc1/Tc2 and Th1/Th2 balance in Asian and Western types of multiple sclerosis, HTLV-I-associated myelopathy/tropical spastic paraparesis and hyperIgEaemic myelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Flow cytometric differentiation of Asian and Western types of multiple sclerosis, HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and hyperIgEaemic myelitis by analyses of memory CD4 positive T cell subsets and NK cell subsets

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Recurrent opticomyelitis associated with anti-DNA antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Anticardiolipin antibodies in Japanese patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Optic-spinal form of multiple sclerosis and anti-thyroid autoantibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Antineutrophil cytoplasmic antibodies and the optic-spinal form of multiple sclerosis in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Clinical, CSF, and MRI findings in Devic's neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Recurrent optic neuromyelitis with endocrinopathies: a new syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Investigating chemokines and chemokine receptors in patients with multiple sclerosis: opportunities and challenges

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Genetic epidemiology of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Changes in the clinical phenotypes of multiple sclerosis during the past 50 years in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Decrease in multiple sclerosis with acute transverse myelitis in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Incidence of multiple sclerosis in Møre and Romsdal, Norway from 1950 to 1991. An age-period-cohort analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Prevalence estimates for MS in the United States and evidence of an increasing trend for women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

Acute necrotic myelopathy with pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900308-9

7 January 2021

10.1016/S1474-4422(03)00308-9

Identifiers

DOI

1 reference

release_b24w7l4d6fbafil3yaqbr2jpwi

26 June 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/b24w7l4d6fbafil3yaqbr2jpwi

24 November 2022

mapped directly with Wikidata item

1 reference